February WKW Frontiers in Neuroscience Lecture Series: Dr. Joan Camprodon

Dr. Joan Camprodon - February 7, 2023 

"Suicide Circuit Therapeutics:  Leveraging the Efficacy of ECT and the Focality of TMS"

William K. Warren, Jr.  Frontiers in Neuroscience Lecture 
12:00 pm - 1:00 pm     Program in the LPCH auditorium  (No registration needed)

Dr. Camprodon is inaugural Chief of the Division of Neuropsychiatry and Director of the Laboratory for Neuropsychiatry and Neuromodulation at Massachusetts General Hospital, and Associate Professor of Psychiatry at Harvard Medical School.
 
Clinically, he is the founding Director of the MGH Transcranial Magnetic Stimulation (TMS) clinical service, a member of the Psychiatric Neurosurgery Committee and an attending physician in the Departments of Psychiatry (Neuropsychiatry) and Neurology (Cognitive and Behavioral Neurology). He is board-certified in psychiatry and behavioral neurology-neuropsychiatry.
 
Dr. Camprodon’s research focuses on Neuropsychiatry and Neuromodulation. Methodologically, he uses multimodal combinations of brain stimulation and neuroimaging/neurophysiology to investigate neural circuitry and plasticity in a translational manner. He uses a wide range of noninvasive and invasive neuromodulation techniques including transcranial current stimulation (tCS, e.g. tDCS/tACS), transcranial magnetic stimulation, transcranial photobiomodulation, electroconvulsive therapy and deep brain stimulation. He also uses multimodal functional and structural MRI, EEG and innovative simultaneous combinations of TMS and tDCS/tACS with neuroimaging and neurophysiology. The scope of his research includes basic, translational and clinical projects focused on human circuit neuroscience. Projects in his laboratory address (1) circuit level neuropsychiatric pathophysiology (with an emphasis on transdiagnostic processes and the role of plasticity) and (3) the translational development of tools to support clinical care and decision-making (e.g. biomarkers and treatment development). Critical efforts are geared towards applying the paradigms and methods of human systems/cognitive neuroscience to discover treatment targets that support the development of individualized precision therapeutics, with a focus on image-guided device-based neuromodulation.

Learning objectives: 

1. To understand the potential of ECT as a translational neuroscience tool for biomarker discovery.
2. To understand the role of the ACC in the pathophysiology of suicide.
3. To learn about the potential of individualized TMS as a rapid anti-suicide therapy.
   
   

For Physicians: Saint Francis Health System is accredited by the Oklahoma State Medical Association to sponsor continuing medical education for physicians.
Saint Francis Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
For Psychologists: The Oklahoma State Board of Examiners of Psychologists, the American Psychological Association and the Oklahoma Psychological Association recognize AMA PRA Category 1  credit™. Saint Francis Health System is accredited by the OSMA
 
For Social Workers: Saint Francis Health System is an approved provider of continuing education for social worker through the Oklahoma State Board of Licensed Social Workers for 1 hour Category 1 Clinical. (CEP Number - 20230007)
 
For CADCs and LADCs Saint Francis Health System is accredited as a provider of continuing education programs for CADCs and LADCs through the Oklahoma Board of Licensed Alcohol and Drug Counselors.      (1 hour)
 
The LPC/LMFT This event as been approved by the State Board of Behavioral Health Licensure (BBHL) for 1 hour of CE.  
 
For questions , email:  Lauren Haguewood at lehaguewood@saintfrancis.com